Organization Overview
Alternative names
dasiglucagon (Zegalogue) (2021)
lixisenatide (adlyxin) (2001)
Congenital Hyperinsulinism (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Heart Failure (Phase 2)
Hyperinsulinism (Phase 3)
Hypoglycemia (Phase 3)
Infarction (Phase 2)
Inflammatory Bowel Diseases (Phase 1)
Myocardial Infarction (Phase 2)
Renal Insufficiency (Phase 1)
Short Bowel Syndrome (Phase 3)
Syndrome (Phase 3)